Coronavirus Notebook: G7 Agree On ‘Clinical Trial Charter’, Regulators Focus On Real World Data
Executive Summary
The European Medicines Agency has issued advice on managing thrombosis with thrombocytopenia syndrome (TTS) in people vaccinated with adenovirus vaccines, and Brazil has OKd the import of Sputnik V and Covaxin, albeit with numerous strings attached.
You may also be interested in...
COVID-19: EMA Says Guillain-Barré Syndrome Is A Side-Effect Of AZ’s Vaxzevria
The EU’s pharmacovigilance committee has recommended safety updates for two COVID-19 vaccines, and is keeping its eye on a range of possible side-effects with all four authorized products.
Will COVID Finally Help US FDA And Sponsors Overcome Their ‘Angst’ On Innovative Trial Designs?
The ‘sea change’ inside White Oak should be seen as very encouraging for sponsors, FDA official says.
Pandemic ‘Roadmap’ Will Show How To Develop New Vaccines in 100 Days
The pharmaceutical industry is a key player in a new partnership that aims to bring the public and private sectors together to address future complex health threats.